This study is focused on males who have Hemophilia B and who need regular preventive treatment with factor IX protein (FIX) replacement therapy to prevent and also to control their bleeding events. The aim of the study is to gather at least 6 months…
- Investigator
- Tung T Wynn
- Ages
- 16 Years - N/A
- Sexes
- Male